Back to
FEDERATED HERMES, INC.
RARE29 quarters
Position history for
FEDERATED HERMES, INC.'s holdings in Ultragenyx Pharmaceutical, Inc.
FEDERATED HERMES, INC. previously held 0 shares of RARE (Ultragenyx Pharmaceutical, Inc.), worth $0 as of 2025-Q4.
Final Value
$0
Final Shares
0
Total Value Change
-$55.5M
Total Shares Change
-1.3M
Quarter-by-Quarter History
Other major holders of RARE: Capital Research Global Investors, BNP PARIBAS FINANCIAL MARKETS, Capital International Investors